Table 1.

Characterisation of the study population according to the groups

Characterisation	Observation number (%) or average±SD
	Leprosy (n=30)	HIV/AIDS (n=30)	HIV/leprosy (n=30)	P*
Average age	52.1±16.6	37.2±11.2	46.6±11.6	0.00017**
Sex
Male	16 (53.3)	20 (66.7)	16 (53.3)	>0.05*
Female	14 (46.7)	10 (33.3)	14 (46.7)
Operational classification
Paucibacillary	11 (36.7)	-	15 (50.0)	>0.05*
Multibacillary	19 (63.3)	-	15 (50.0)
HAART time
0–4 years old	-	19 (63.3)	11 (36.6)
5–9 years old	-	5 (16.7)	13 (43.4)	>0.05*
10–14 years old	-	3 (10.0)	4 (13.3)
≥15 years old	-	3 (10.0)	2 (6.7)
Time to HIV diagnosis
0–4 years old	-	18 (60.0)	10 (33.3)
5–9 years old	-	4 (13.3)	14 (46.7)	0.0460*
10–14 years old	-	5 (16.7)	4 (13.3)
≥15 years old	-	3 (10.0)	2 (6.7)

AIDS=acquired immunodeficiency syndrome, HIV=human immunodeficiency virus, SD=standard deviation, HAART=highly active antiretroviral therapy. *G (Williams) test, **ANOVA test